Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01315041
Other study ID # Pi2011
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received March 14, 2011
Last updated January 26, 2016
Start date December 2014
Est. completion date January 2016

Study information

Verified date January 2016
Source Casa Espirita Terra de Ismael
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

Hot flushes are common symptoms in women after menopause, and are important causes of discomfort and lead to high number of medical consultations. Hormone replacement therapy is an effective treatment, however it can bring undesirable consequences and may be contraindicated for some women. Options are inhibitors of serotonin or serotonin-norepinephrine reuptake, gabapentin, herbal medicines and homeopathy. None of these therapies is widely accepted of effective. Therefore, the search for new therapeutic options is highly desirable. Ingestion of malagueta pepper fruits (Capsicum frutescens L. var. malagueta) causes sensations similar to those experienced by menopausal women during hot flushes. By the principle of homeopathy, "the like cures the like", the objectives of this study are: (a) to determinate whether pathogenesis of a homeopathic medicine made from C. frutescens fruits include symptoms like hot flushes, and (b) whether this medicine is effective on hot flushes relief in women after menopause. There will be 2 distinct phases. Phase 1 is the determination of the medicine's pathogenesis in healthy volunteers, in a randomized placebo-controlled, double-blind design. Phase 2 is the investigation of the medicine's effects on hot flushes of women after menopause, in a randomized placebo-controlled, double-blind design. The investigators expect a significant reduction on symptoms perception, assessed by internationally validated tools. The study is expected to last for 18 months, with 36 patients included in each phase.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 2016
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Phase 1: healthy volunteers

- Phase 2: menopaused women with hot flushes

Exclusion Criteria:

- Illiteracy;

- Have been enrolled in another clinical trial within the last 6 months;

- Use of pharmacological therapies for hot flushes;

- Have any degree of vulnerability;

- Allergy or hypersensitivity to Capsicum species;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Capsicum frutescens fruits, homeopathic medicine
5 drops, PO, 3 times a day, during 16 weeks
Inert alcoholic solution
5 drops, PO, 3 times a day, during 16 weeks

Locations

Country Name City State
Brazil Casa Espirita Terra de Ismael Jardinopolis SP

Sponsors (2)

Lead Sponsor Collaborator
Casa Espirita Terra de Ismael University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary MYMOP (Measure Yourself Medical Outcome Profile) 4 and 16 weeks No
Primary ORIDL (Outcome Related to Impact on Daily Living) 4 and 16 weeks No